Efficacy of Complex Decongestive Therapy, Exercise and Diet in Women With Lipedema
1 other identifier
interventional
75
1 country
1
Brief Summary
The purpose of this study is to compare the effectiveness of standard physical therapy methods (Complex Decongestive Therapy, Pneumatic Compression, and Exercise) combined with two different nutritional approaches (personalized anti-inflammatory diet vs. standard healthy nutrition education) in women diagnosed with lower extremity lipedema.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2026
CompletedFirst Posted
Study publicly available on registry
June 25, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2027
July 29, 2026
July 1, 2026
1.4 years
April 11, 2026
July 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Lower Extremity Circumference
Lower extremity circumferences will be measured in centimeters (cm) using a standardized tape measure at predefined anatomical landmarks, including the foot dorsum, ankle, and at 10-cm intervals proximally below the knee, as well as at the thigh. Change in lower extremity circumference from baseline will be evaluated within and between study groups.
Baseline, Week 6, and Week 12
Secondary Outcomes (15)
Change in Body Weight
Baseline, Week 6, and Week 12
Change in Subcutaneous tissue thickness (mm)
Baseline, Week 6, and Week 12
Change in Dermis thickness (mm)
Baseline, Week 6, and Week 12
Change in Fibrous Septa Prominence
Baseline, Week 6, and Week 12
Change in Subcutaneous Fat Tissue Echogenicity
Baseline, Week 6, and Week 12
- +10 more secondary outcomes
Study Arms (2)
Anti-inflammatory Diet + Physical Therapy
EXPERIMENTALParticipants in this arm will receive a personalized anti-inflammatory diet plan formulated by the Physical Medicine and Rehabilitation clinic, in addition to a standard 12-week physical therapy protocol (Complex Decongestive Therapy, Intermittent Pneumatic Compression, and exercise).
Standard Diet + Physical Therapy
ACTIVE COMPARATORParticipants in this arm will receive standard healthy nutrition education, in addition to a standard 12-week physical therapy protocol (Complex Decongestive Therapy, Intermittent Pneumatic Compression, and exercise).
Interventions
A personalized anti-inflammatory diet plan formulated by the clinic, combined with a 12-week standard physical therapy protocol. The physical therapy includes compression garments (CCL2), Manual Lymphatic Drainage (MLD), Intermittent Pneumatic Compression (IPC), and an exercise program.
Standard healthy nutrition education, combined with a 12-week standard physical therapy protocol. The physical therapy includes compression garments (CCL2), Manual Lymphatic Drainage (MLD), Intermittent Pneumatic Compression (IPC), and an exercise program.
Eligibility Criteria
You may qualify if:
- Female, aged 18 to 65 years.
- Clinical and physical examination confirming Stage I, II, or III lipedema.
- Body Mass Index (BMI) \< 45 kg/m\^2.
- Ability to walk without restriction.
You may not qualify if:
- Presence of active malignancy.
- Decompensated heart failure.
- Significant lower extremity peripheral artery disease.
- Acute deep vein thrombosis or active thromboembolism.
- Pregnancy.
- Significant sensory loss or severe neuropathy in the lower extremities.
- History of lower extremity liposuction within the last 12 months.
- Active severe infection (e.g., cellulitis).
- Other severe systemic diseases deemed unsafe for the study by researchers.
- Severe non-compliance with the study protocol (e.g., missing \>30% of planned sessions) or participant requesting withdrawal.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Balikesir University Faculty of Medicine Hospital
Balıkesir, 10145, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nilay Sahin, Prof. Dr.
Balikesir University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcomes assessor, who will perform the clinical measurements, ultrasound evaluations, and questionnaires at baseline and all follow-up time points, will be blinded to the group allocation of the participants.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
April 11, 2026
First Posted
June 25, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
December 15, 2027
Study Completion (Estimated)
December 15, 2027
Last Updated
July 29, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share